long term health effects of glp 1 New Research on GLP-1s & Bone 🦴 ​A new large-scale study has raised questions about the long-term GLP-1 receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary dangers of glp 1 drugs

This specific property has become the focus of numerous research strategies, such as the development of senolytic agents like FOXO4-DRI, which selectively disrupt the FOXO4p53 interaction, thereby enabling the targeted elimination of dysfunctional cells

PlexusDx recommends starting at 0.25 mg and titrating weekly to find your optimal dosethis approach maximizes tolerance, minimizes side effects, and produces steady, sustainable weight loss

Long-term GLP-1 therapy has been studied in trials lasting over two years with established safety profiles

Safety Profile & Reported Adverse Effects The Phase 2b trial (PMID: 23714218) reported a favorable short-term safety profile with no serious adverse events attributed to AOD-9604

doi: 10.1179/135100099101534648